Skip to main content
Fig. 1 | Trials

Fig. 1

From: Does a ketogenic diet as an adjuvant therapy for drug treatment enhance chemotherapy sensitivity and reduce target lesions in patients with locally recurrent or metastatic Her-2-negative breast cancer? Study protocol for a randomized controlled trial

Fig. 1

Schedule of enrollment, interventions, and assessments. Laboratory testing will acquire hematological data (hemoglobin, white blood cell count, blood glucose, blood ketones, blood lipids, neutrophil count, and platelet count), biochemical data (total bilirubin, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, serum creatinine, total protein, sodium ions, potassium ions, magnesium ions, chloride, calcium, urea, and thyroid function), pregnancy status (if applicable), tumor-marker data (CA153 and carcino-embryonic antigen), routine urinary data (urine glucose, urinary ketones, urine protein), and imaging data (computed tomography/magnetic resonance imaging of target lesions). EORTC QLQ-C30, version 3 the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30, ECOG PS Eastern Cooperative Oncology Group Performance Status

Back to article page

Trials

ISSN: 1745-6215